Injective price drops — what’s behind today’s move (January 7)

Injective price drops — what’s behind today’s move (January 7)
Injective Slides 10.00% Today

Injective (INJ) is trading at $5.25, positioned above its MA-20 ($4.74) but just below its MA-50 ($5.28), and well under the long-term MA-200 ($10.10). This setup signals a short-term bullish tilt, with medium-term resistance from the MA-50 and persistent long-term selling pressure.

INJ price prediction
24H -7.67%
$5.54
48H -7.83%
$5.53
7D 0.17%
$6.01
1M 3.33%
$6.2
3M 145.17%
$14.71
6M 113.5%
$12.81
12M 93%
$11.58
Current price: $ 6 0.74 14.13%
Real-time Data 10:46
Daily range 5.46 Arrow from to Icon 6.02
Weekly range 4.89 Arrow from to Icon 5.75
Loading...

Highlights

  • No news data is available for the target dates, providing no relevant updates or financial figures for professional investors.
  • The article does not contain any market-moving events, earnings reports, or regulatory developments affecting listed companies or sectors.
  • Investors receive no new material information or key performance indicators, impacting analysis, trading decisions, and portfolio adjustments for the period in question.

Anton Kharitonov, expert at Traders Union, sees INJ trading at a technical crossroads. The price sits above the MA-20 but struggles to reclaim the MA-50, and remains far below its MA-200 level. Momentum signals conflict, with bullish RSI but overbought Stoch RSI and CCI increasing downside risk. The absence of fundamental news leaves the market exposed to technical shifts and possible exhaustion from recent gains. "I see short-term upside as vulnerable here, with sellers likely to push lower if support at $5.03 fails."

Viktoras Karapetjanc, expert at Traders Union, notes a resilient structure for INJ as key supports hold despite volatility. He believes that bullish momentum remains underpinned by investor optimism even if news catalysts are lacking. Karapetjanc sees scope for the price to stabilize and potential for renewed growth should resistance at the MA-50 be breached. "Given the consolidation above recent supports, I expect the bullish structure to persist and further growth toward $5.60 is within reach if momentum shifts."

Mixed momentum signals as overbought readings and volatility weigh

Momentum signals are mixed for INJ. The daily MACD is neutral and the ADX points to ongoing buying activity. While INJ's RSI is in bullish territory and the Awesome Oscillator supports a positive daily bias, Stoch RSI and CCI show overbought conditions, suggesting a risk for short-term pullback. BBP indicates buyers are still in control, but heightened volatility and a drop toward the session’s lows highlight intraday seller pressure. Dynamic support is near the Ichimoku Kijun at $5.03 and MA-50 levels just above, with the price remaining range-bound between $5.31 and $5.60 after today’s notable decline.

Previously it was reported that Injective saw heightened volatility, declining sharply yet staying above its short- and medium-term moving averages while remaining well under long-term resistance, with mixed technical indicators reflecting both continued buyer interest and caution amid overbought conditions. Immediate support and resistance clustered around the $5.03–$5.60 range, and analysts projected a mostly sideways or lower trajectory over the next week, with the probability of sustained increases viewed as low.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.